New Research Shows Blood-Thinning Treatment Standards Changing For Heart Patients
Katie Pence, University of Cincinnati Academic Health Center
Researchers at the University of Cincinnati and Massachusetts General Hospital
have found that warfarin, a known anticoagulation (blood-thinning) drug, may
not be as beneficial to some patients with atrial fibrillation as previously
National Stroke Association’s mission is to reduce the incidence and impact of stroke by developing compelling education and programs focused on prevention, treatment, rehabilitation and support for all impacted by stroke.